David Jochheim
Ludwig Maximilian University of Munich
35 Papers
54 Citations
David Jochheim is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Medicine & Valve replacement. The author has an hindex of 12, co-authored 34 publications.
Chat about Author
Papers
5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial
Mohamed Abdel-Wahab,Martin Landt,Franz-Josef Neumann,Steffen Massberg,Christian Frerker,Thomas Kurz,Jatinderjit Kaur,Ralph Toelg,Susanne Sachse,David Jochheim,Ulrich Schäfer,Mohamed El-Mawardy,Derek R. Robinson,Gert Richardt,Choice Investigators +14 more
TL;DR: Five-year follow-up of patients in the CHOICE trial revealed clinical outcomes after transfemoral transcatheter aortic valve replacement with early-generation BE and SE valves that were not statistically significantly different, with limited statistical power.
176
Coronary CT angiography derived morphological and functional quantitative plaque markers correlated with invasive fractional flow reserve for detecting hemodynamically significant stenosis
Christian Tesche,Carlo N. De Cecco,Carlo N. De Cecco,Damiano Caruso,Damiano Caruso,Stefan Baumann,Stefan Baumann,Matthias Renker,Matthias Renker,Stefanie Mangold,Stefanie Mangold,Kevin T. Dyer,Akos Varga-Szemes,Moritz Baquet,David Jochheim,Ullrich Ebersberger,Richard R. Bayer,Ellen Hoffmann,Daniel H. Steinberg,U. Joseph Schoepf +19 more
TL;DR: TPV, NCPV, CCO, and cFFR derived from CCTA can aid detecting hemodynamically significant coronary lesions with cffR showing the greatest discriminatory ability.
68
Randomized Comparison of Intensified and Standard P2Y12-Receptor-Inhibition Before Elective Percutaneous Coronary Intervention: The SASSICAIA Trial.
Julinda Mehilli,Moritz Baquet,Willibald Hochholzer,Katharina Mayer,Christian Tesche,Daniel Aradi,Yujun Xu,Manuela Thienel,Sarah Gschwendtner,Magda Zadrozny,David Jochheim,Dirk Sibbing,Stefanie Schüpke,Ulrich Mansmann,Ellen Hoffmann,Adnan Kastrati,Franz-Josef Neumann,Steffen Massberg +17 more
TL;DR: In biomarker-negative stable and unstable angina patients undergoing elective PCI, the trial did not find a conclusive difference in efficacy or safety, and this observation should be interpreted in the context of wide CIs and premature termination of the trial.
38
Aortic regurgitation with second versus third-generation balloon-expandable prostheses in patients undergoing transcatheter aortic valve implantation.
David Jochheim,Magda Zadrozny,Hans D. Theiss,Moritz Baquet,Fatima Maimer-Rodrigues,Axel Bauer,Philipp S. Lange,Martin Greif,Christian Kupatt,Jörg Hausleiter,Christian Hagl,Steffen Massberg,Julinda Mehilli +12 more
TL;DR: Compared to the SXT, the use of the S3 prosthesis substantially reduces post-TAVI aortic regurgitation, and longer follow-up is needed to assess if this finding translates to better clinical outcomes.
Contrast-induced acute kidney injury after computed tomography prior to transcatheter aortic valve implantation
David Jochheim,V.-S. Schneider,Florian Schwarz,Christian Kupatt,Philipp S. Lange,Maximilian F. Reiser,Steffen Massberg,J.-L. Gutiérrez-Chico,Julinda Mehilli,Hans Christoph Becker +9 more
TL;DR: One in ten elderly patients with aortic stenosis undergoing MDCT to plan a TAVI procedure experienced CI-AKI after intravenous ICM injection, indicating that intravenous administration of <90 ml of ICM reduces this risk in patients with or without pre-existing impaired renal function.
31